111 related articles for article (PubMed ID: 1706573)
1. Characterization of reverse transcriptase activity and susceptibility to other nucleosides of AZT-resistant variants of HIV-1. Results from the Canadian AZT Multicentre Study.
Wainberg MA; Tremblay M; Rooke R; Blain N; Soudeyns H; Parniak MA; Yao XJ; Li XG; Fanning M; Montaner JS
Ann N Y Acad Sci; 1990; 616():346-55. PubMed ID: 1706573
[No Abstract] [Full Text] [Related]
2. Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera.
Albert J; Wahlberg J; Lundeberg J; Cox S; Sandström E; Wahren B; Uhlén M
J Virol; 1992 Sep; 66(9):5627-30. PubMed ID: 1380098
[TBL] [Abstract][Full Text] [Related]
3. [Resistance to azidothymidine in human immunodeficiency virus (HIV) infection].
Karmanov EV; Lukashov VV
Mol Biol (Mosk); 1994; 28(1):7-20. PubMed ID: 7511784
[TBL] [Abstract][Full Text] [Related]
4. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.
St Clair MH; Martin JL; Tudor-Williams G; Bach MC; Vavro CL; King DM; Kellam P; Kemp SD; Larder BA
Science; 1991 Sep; 253(5027):1557-9. PubMed ID: 1716788
[TBL] [Abstract][Full Text] [Related]
5. Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells.
Smith MS; Koerber KL; Pagano JS
J Infect Dis; 1993 Feb; 167(2):445-8. PubMed ID: 7678429
[TBL] [Abstract][Full Text] [Related]
6. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients.
Mohri H; Singh MK; Ching WT; Ho DD
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):25-9. PubMed ID: 7678340
[TBL] [Abstract][Full Text] [Related]
8. Reverse transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS.
Gurusinghe AD; Land SA; Birch C; McGavin C; Hooker DJ; Tachedjian G; Doherty R; Deacon NJ
J Med Virol; 1995 Jul; 46(3):238-43. PubMed ID: 7561796
[TBL] [Abstract][Full Text] [Related]
9. [Stability of human immunodeficiency virus to azidothymidine. II. Kinetic characteristics of "AZT-resistant" mutant forms of reverse transcriptase].
Pokholok DK; Gudima SO; Memelova LV; Esipov DS; Rechinskiĭ VO; Kochetkov SN
Biokhimiia; 1996 Jan; 61(1):142-51. PubMed ID: 8679772
[TBL] [Abstract][Full Text] [Related]
10. In vitro study of resistance-associated genotypic mutations to nucleoside analogs.
Gashnikova N; Plyasunova O; Kiseleva Y; Fedyuk N; Pokrovsky A
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):991-4. PubMed ID: 14565328
[TBL] [Abstract][Full Text] [Related]
11. [Interaction of primers with mutant forms of human immunodeficiency virus reverse transcriptase].
Zakharova OD; Suturina OA; Gudima SO; Pokholok DK; Iamkovoĭ VI; Kochetkov SN; Nevinskiĭ GA
Mol Biol (Mosk); 1996; 30(1):231-40. PubMed ID: 8714140
[No Abstract] [Full Text] [Related]
12. Nucleoside drug resistance in HIV-1 reverse transcriptase.
Yadav PN; Yadav JS; Modak MJ
Nat Struct Biol; 1995 Mar; 2(3):193-5. PubMed ID: 7539709
[No Abstract] [Full Text] [Related]
13. [Molecular basis and clinical significance of HIV-1 resistance to nucleoside compounds].
Wainberg MA; Gu Z; Salomon H; Arts EJ; Kleiman L; Parniak MA; Morin N
C R Acad Sci III; 1995 Mar; 318(3):315-28. PubMed ID: 7540494
[TBL] [Abstract][Full Text] [Related]
14. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
Dis Markers; 1990; 8(3):163-4. PubMed ID: 1703061
[No Abstract] [Full Text] [Related]
15. Analysis of resistance mutants of viral polymerases.
Oxford JS; al-Jabri AA; Stein CA; Levantis P
Methods Enzymol; 1996; 275():555-600. PubMed ID: 9026659
[No Abstract] [Full Text] [Related]
16. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
Larder BA; Kemp SD
Science; 1989 Dec; 246(4934):1155-8. PubMed ID: 2479983
[TBL] [Abstract][Full Text] [Related]
17. Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains.
Sheehy N; Desselberger U
J Gen Virol; 1993 Feb; 74 ( Pt 2)():223-8. PubMed ID: 7679140
[TBL] [Abstract][Full Text] [Related]
18. AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells.
Rooke R; Tremblay M; Wainberg MA
Virology; 1990 May; 176(1):205-15. PubMed ID: 1691885
[TBL] [Abstract][Full Text] [Related]
19. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Tisdale M; Kemp SD; Parry NR; Larder BA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
[TBL] [Abstract][Full Text] [Related]
20. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development.
de Clercq E
Med Res Rev; 1996 Mar; 16(2):125-57. PubMed ID: 8656777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
